Company profile
SIGA Technologies, Inc.
NASDAQ: SIGA · Healthcare · Drug Manufacturers - Specialty & Generic
#357 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
73BFH 87DQ 68GM 44SS 70
v0.1 · 65/100 weight · provisional
↑ operating margin, net margin · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$93.8M
Rev growth YoY (TTM)
-22.1%
Net income (FY)
$23.3M
Employees
49
as of 2026-08-13
Market cap
$205.8M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$94.6M$94.6M2025
Net income$23.3M$23.3M2025
Operating income$23.7M$23.7M2025
Total assets$219.5M$219.5M2025
Liabilities$20.6M$20.6M2025
Equity$198.8M$198.8M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product Sales and Supportive Services93%
Research and Development7%
By geography
UNITED STATES88%
CANADA6%
Non-US6%
The read
What is SIGA Technologies, Inc.’s revenue?
SIGA Technologies, Inc. booked $94.6M in FY2025 revenue, contracting 32% year over year — slower than 76% of Healthcare companies we track, at a 24.6% net margin.
Peers · Healthcare
Medexus Pharmaceuticals Inc.64CButterfly Network, Inc.62CBioLife Solutions, Inc.74BPulmonx Corporation57CVaso Corporation68BCeriBell, Inc.49DNeighbors
New York →Key facts
CEODiem Nguyen
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNew York City, NY
ExchangeNASDAQ: SIGA
Employees49
IPO date1997-09-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.